From selenoprotein to endochondral ossification: A novel mechanism with microRNAs potential in bone related diseases?

Medical Hypotheses

Volumn 77, Issue 5, 2011, Pages 807-811

  Sun, Jian ^a,b   Sun, Qingzhu ^a,b   Lu, Shemin ^a,b  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; SELENIUM; SELENOPROTEIN;

ARTICLE; BONE DEVELOPMENT; BONE DISEASE; CARTILAGE CELL; CELL DIFFERENTIATION; CHONDROPATHY; ENCHONDRAL OSSIFICATION; HUMAN; NONHUMAN; OSTEOCHONDROPATHY; PROTEIN EXPRESSION;

BONE DEVELOPMENT; BONE DISEASES; HUMANS; MICRORNAS; SELENOPROTEINS;

EUKARYOTA;

EID: 80053963163     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.07.042     Document Type: Article

References (65)

1. Kronenberg H.M. Developmental regulation of the growth plate. Nature 2003, 423:332-336.
2. Mackie E.J., Ahmed Y.A., Tatarczuch L., Chen K.S., Mirams M. Endochondral ossification: how cartilage is converted into bone in the developing skeleton. International Journal of Biochemistry & Cell Biology 2008, 40:46-62.
3. Cao J., Li S., Shi Z., et al. Articular cartilage metabolism in patients with Kashin-Beck Disease: an endemic osteoarthropathy in China. Osteoarthritis and Cartilage 2008, 16:680-688.
4. Ren F.L., Guo X., Zhang R.J., et al. Effects of selenium and iodine deficiency on bone, cartilage growth plate and chondrocyte differentiation in two generations of rats, Osteoarthritis and cartilage/OARS. Osteoarthritis Research Society 2007, 15:1171-1177.
5. Downey C.M., Horton C.R., Carlson B.A., et al. Osteo-chondroprogenitor-specific deletion of the selenocysteine tRNA gene, Trsp, leads to chondronecrosis and abnormal skeletal development: a putative model for Kashin-Beck disease. PLoS genetics 2009, 5:e1000616.
6. C. Duan, X. Guo, X.D. Zhang, et al., Comparative analysis of gene expression profiles between primary knee osteoarthritis and an osteoarthritis endemic to Northwestern China, Kashin-Beck disease, Arthritis and rheumatism 62, 771-780.
7. Moreno-Reyes R., Mathieu F., Boelaert M., et al. Selenium and iodine supplementation of rural Tibetan children affected by Kashin-Beck osteoarthropathy. American Journal of Clinical Nutrition 2003, 78:137-144.
8. Zeng H.W. Selenium as an essential micronutrient: roles in cell cycle and apoptosis. Molecules 2009, 14:1263-1278.
9. Kryukov G.V., Castellano S., Novoselov S.V., et al. Characterization of mammalian selenoproteomes. Science (New York, NY) 2003, 300:1439-1443.
10. Lu J., Holmgren A. Selenoproteins. Journal of Biological Chemistry 2009, 284:723-727.
11. Kohrle J., Jakob F., Contempre B., Dumont J.E. Selenium, the thyroid, and the endocrine system. Endocrine Reviews 2005, 26:944-984.
12. Dreher I., Schutze N., Baur A., et al. Selenoproteins are expressed in fetal human osteoblast-like cells. Biochemical and biophysical research communications 1998, 245:101-107.
13. Jakob F., Becker K., Paar E., Ebert-Duemig R., Schutze N. Expression and regulation of thioredoxin reductases and other selenoproteins in bone. Methods in Enzymology 2002, 347:168-179.
14. Ebert-Dumig R., Schutze N., Jakob F. The thioredoxin reductase/thioredoxin system in cells of the monocyte/macrophage pathway of differentiation. BioFactors (Oxford, England) 1999, 10:227-235.
15. Shen Q., Chada S., Whitney C., Newburger P.E. Regulation of the human cellular glutathione peroxidase gene during in vitro myeloid and monocytic differentiation. Blood 1994, 84:3902-3908.
16. Schutze N., Fritsche J., Ebert-Dumig R., et al. The selenoprotein thioredoxin reductase is expressed in peripheral blood monocytes and THP1 human myeloid leukemia cells--regulation by 1,25-dihydroxyvitamin D3 and selenite. BioFactors (Oxford, England) 1999, 10:329-338.
17. Mustacich D., Powis G. Thioredoxin reductase. The Biochemical Journal 2000, 346 Pt 1:1-8.
18. Schutze N., Lechner A., Groll C., et al. The human analog of murine cystein rich protein 61 [correction of 16] is a 1alpha, 25-dihydroxyvitamin D3 responsive immediate early gene in human fetal osteoblasts: regulation by cytokines, growth factors, and serum. Endocrinology 1998, 139:1761-1770.
19. Kumar S., Hand A.T., Connor J.R., et al. Identification and cloning of a connective tissue growth factor-like cDNA from human osteoblasts encoding a novel regulator of osteoblast functions. The Journal of Biological Chemistry 1999, 274:17123-17131.
20. Lau L.F., Lam S.C. The CCN family of angiogenic regulators: the integrin connection. Experimental Cell Research 1999, 248:44-57.
21. Schutze N., Bachthaler M., Lechner A., Kohrle J., Jakob F., et al. Identification by differential display PCR of the selenoprotein thioredoxin reductase as a 1 alpha,25(OH)2-vitamin D3-responsive gene in human osteoblasts - regulation by selenite. BioFactors (Oxford England) 1998, 7:299-310.
22. Gouveia C.H., Christoffolete M.A., Zaitune C.R., et al. Type 2 iodothyronine selenodeiodinase is expressed throughout the mouse skeleton and in the MC3T3-E1 mouse osteoblastic cell line during differentiation. Endocrinology 2005, 146:195-200.
23. Morimura T., Tsunekawa K., Kasahara T., et al. Expression of type 2 iodothyronine deiodinase in human osteoblast is stimulated by thyrotropin. Endocrinology 2005, 146:2077-2084.
24. Miura M., Tanaka K., Komatsu Y., et al. Thyroid hormones promote chondrocyte differentiation in mouse ATDC5 cells and stimulate endochondral ossification in fetal mouse tibias through iodothyronine deiodinases in the growth plate. Journal of Bone and Mineral Research 2002, 17:443-454.
25. Meulenbelt I., Min J.L., Bos S., et al. Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis. Human Molecular Genetics 2008, 17:1867-1875.
26. Bos S.D., Kloppenburg M., Suchiman E., van Beelen E., Slagboom P.E., Meulenbelt I., et al. The role of plasma cytokine levels, CRP and Selenoprotein S gene variation in OA. Osteoarthritis and Cartilage 2009, 17:621-626.
27. Mathy-Hartert M., Hogge L., Sanchez C., Deby-Dupont G., Crielaard J.M., Henrotin Y. Interleukin-1 beta and interleukin-6 disturb the antioxidant enzyme system in bovine chondrocytes: a possible explanation for oxidative stress generation. Osteoarthritis and Cartilage 2008, 16:756-763.
28. Kabuyama Y., Kitamura T., Yamaki J., Homma M.K., Kikuchi S., Homma Y. Involvement of thioredoxin reductase 1 in the regulation of redox balance and viability of rheumatoid synovial cells. Biochemical and Biophysical Research Communications 2008, 367:491-496.
29. Shen S., Berry W., Jaques S., Pillai S., Zhu J. Differential expression of iodothyronine deiodinase type 2 in growth plates of chickens divergently selected for incidence of tibial dyschondroplasia. Animal Genetics 2004, 35:114-118.
30. Y.M. Xiong, X.Y. Mo, X.Z. Zou, et al., Association study between polymorphisms in selenoprotein genes and susceptibility to Kashin-Beck disease, Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 18, 817-824.
31. Moreno-Reyes R., Egrise D., Neve J., Pasteels J.L., Schoutens A. Selenium deficiency-induced growth retardation is associated with an impaired bone metabolism and osteopenia. Journal of Bone and Mineral Research 2001, 16:556-1563.
32. Becker K., Gromer S., Schirmer R.H., Muller S. Thioredoxin reductase as a pathophysiological factor and drug target. European Journal of Biochemistry/FEBS 2000, 267:6118-6125.
33. Melhus H., Michaelsson K., Holmberg L., Wolk A., Ljunghall S., et al. Smoking, antioxidant vitamins, and the risk of hip fracture. Journal of Bone and Mineral Research 1999, 14:129-135.
34. Savaskan N.E., Borchert A., Brauer A.U., Kuhn H. Role for glutathione peroxidase-4 in brain development and neuronal apoptosis: Specific induction of enzyme expression in reactive astrocytes following brain injury. Free Radical Biology and Medicine 2007, 43:191-201.
35. Ufer C., Wang C.C., Fahling M., et al. Translational regulation of glutathione peroxidase 4 expression through guanine-rich sequence-binding factor 1 is essential for embryonic brain development. Genes & Development 2008, 22:1838-1850.
36. Selvaraj N., Bobby Z., Sridhar M.G. Is euthyroid sick syndrome a defensive mechanism against oxidative stress?. Medical Hypotheses 2008, 71:404-405.
37. Driscoll D.M., Copeland P.R. Mechanism and regulation of selenoprotein synthesis. Annual Review of Nutrition 2003, 23:17-40.
38. Squires J.E., Berry M.J. Eukaryotic selenoprotein synthesis: Mechanistic insight incorporating new factors and new functions for old factors. IUBMB Life 2008, 60:232-235.
39. Takeuchi A., Schmitt D., Chapple C., et al. A short motif in Drosophila SECIS Binding Protein 2 provides differential binding affinity to SECIS RNA hairpins. Nucleic Acids Research 2009, 37:2126-2141.
40. Donovan J., Caban K., Ranaweera R., Gonzalez-Flores J.N., Copeland P.R. A novel protein domain induces high affinity selenocysteine insertion sequence binding and elongation factor recruitment. Journal of Biological Chemistry 2008, 283:35129-35139.
41. Papp L.V., Wang J., Kennedy D., et al. Functional characterization of alternatively spliced human SECISBP2 transcript variants. Nucleic Acids Research 2008, 36:7192-7206.
42. Anestål K., Arnér E.S. Rapid induction of cell death by selenium-compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine. Journal of Biological Chemistry 2003, 278:15966-15972.
43. Berezikov E., Guryev V., van de Belt J., Wienholds E., Plasterk R.H.A., Cuppen E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 2005, 120:21-24.
44. Xie X.H., Lu J., Kulbokas E.J., et al. Systematic discovery of regulatory motifs in human promoters and 3 UTRs by comparison of several mammals. Nature 2005, 434:338-345.
45. Sanchez-Beato M., Sanchez-Aguilera A., Piris M.A. Cell cycle deregulation in B-cell lymphomas. Blood 2003, 101:1220-1235.
46. Wienholds E., Kloosterman W.P., Miska E., et al. MicroRNA expression in zebrafish embryonic development. Science (New York, NY) 2005, 309:310-311.
47. Tuddenham L., Wheeler G., Ntounia-Fousara S., et al. The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Letters 2006, 580:4214-4217.
48. Kobayashi T., Lu J., Cobb B.S., et al. Dicer-dependent pathways regulate chondrocyte proliferation and differentiation. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:1949-1954.
49. O'Donnell K.A., Wentzel E.A., Zeller K.I., Dang C.V., Mendell J.T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005, 435:839-843.
50. Mizuno Y., Tokuzawa Y., Ninomiya Y., et al. miR-210 Promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Letters 2009, 583:2263-2268.
51. Li Z., Hassan M.Q., Volinia S., et al. A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:13906-13911.
52. Lin E.A., Kong L., Bai X.H., Luan Y., Liu C.J., et al. miR-199a, A bone morphogenic protein 2-responsive MicroRNA, regulates chondrogenesis via direct targeting to Smad1. The Journal of Biological Chemistry 2009, 284:11326-11335.
53. Itoh T., Nozawa Y., Akao Y. MicroRNA-141 and -200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5. The Journal of Biological Chemistry 2009, 284:19272-19279.
54. Inose H., Ochi H., Kimura A., et al. A microRNA regulatory mechanism of osteoblast differentiation. Proceedings of the National Academy of Sciences of the United States of America 2009.
55. Kahai S., Lee S.C., Lee D.Y., et al. MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7. PLoS ONE 2009, 4:e7535.
56. Schoolmeesters A., Eklund T., Leake D., et al. Functional profiling reveals critical role for miRNA in differentiation of human mesenchymal stem cells. PLoS ONE 2009, 4:e5605.
57. Li H., Xie H., Liu W., et al. A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. Journal of Clinical Investigation 2009, 119:3666-3677.
58. McGlinn E., Yekta S., Mansfield J.H., Soutschek J., Bartel D.P., Tabin C.J. In ovo application of antagomiRs indicates a role for miR-196 in patterning the chick axial skeleton through Hox gene regulation. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:18610-18615.
59. Ohgawara T., Kubota S., Kawaki H., et al. Regulation of chondrocytic phenotype by micro RNA 18a: Involvement of Ccn2/Ctgf as a major target gene. FEBS Letters 2009, 583:1006-1010.
60. Li Z.Y., Hassan M.Q., Jafferji M., et al. Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. Journal of Biological Chemistry 2009, 284:15676-15684.
61. Mayoral R.J., Pipkin M.E., Pachkov M., van Nimwegen E., Rao A., Monticelli S. MicroRNA-221-222 regulate the cell cycle in mast cells. Journal of Immunology 2009, 182:433-445.
62. Sugatani T., Hruska K.A. Impaired micro-RNA pathways diminish osteoclast differentiation and function. Journal of Biological Chemistry 2009, 284:4667-4678.
63. Luzi E., Marini F., Sala S.C., Tognarini I., Galli G., Brandi M.L. Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor. Journal of Bone and Mineral Research 2008, 23:287-295.
64. Kapinas K., Kessler C.B., Delany A.M. miR-29 Suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling. Journal of Cellular Biochemistry 2009, 108:216-224.
65. Suomi S., Taipaleenmaki H., Seppaenen A., et al. MicroRNAs regulate osteogenesis and chondrogenesis of mouse bone marrow stromal cells. Cellular Oncology 2008, 30:274.